A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis
Clinical trial NCT06859294 · TERMINATED
Trial details
- NCT number
- NCT06859294
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-19
- Primary completion
- 2025-11-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.